Sentence examples for despite active research from inspiring English sources
Despite active research, treatment for endothelial dysfunction remains widely lacking; this opens an interest among researchers to explore new therapeutic options for the prevention of endothelial leakage.
Neither antiviral drugs nor vaccines are approved for veterinary or medical use despite active research on this area.
Despite active research in the area, several aspects of vRNP transport from the nucleus to the plasma membrane remain poorly understood.
Despite active research in the field of tissue engineered heart valves there have been limited efforts to optimize the balance between biodegradation of the scaffolds and de novo extracellular matrix (ECM) synthesis by cells and study their consequences on the mechanical properties of the cell-seeded construct.
Despite active research in the field, the precise role(s) of different ALDH isoforms in stem cells remains enigmatic.
Among potential biochemical biomarkers, despite active research and numerous candidates, none is sufficiently validated and recognized for systematic use in drug development of OA or in clinical practice to identify patients who should be treated.
Despite the active research effort in the field, at the moment, issues related to the operation and control of these networks, as well as sizing, are still uncertain.
Despite much active research into biomarkers in osteoarthritis, 10 16 no single biomarker stands out as the gold standard or is sufficiently well validated and recognised for systematic use in drug development.
Despite the active research in the field, most of the published data concerning host-pathogen interactions [ 17- 28] are not available for the study in the concert with other data: they can be accessed only as supplemental tables to the papers and at best visualized using the network visualization and navigation tools, such as Cytoscape [ 29], GenMAPP [ 30], GeneSpring (Agilent).
Despite decades of active research, an efficacious vaccine mediating long-term protection is still not available.
OmoMYC on its own displays poor delivery across physiological barriers to the desired cellular compartment and thus, despite decades of active research, the therapeutic use of OmoMYC has been impaired by the lack of tumor cell penetration in vivo.
